Osteoporosis Trial, Recruiting NCT05732870 Sponsor: Relation Therapeutics Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT05732870
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with osteoarthritis who are having joint replacement, bone realignment, or joint fusion surgery on any joint, including the hip, knee, shoulder, wrist, elbow, or ankle.
  • People with a broken hip bone who are having a partial or full hip replacement, or another type of surgery to fix the break internally.
  • People having surgery to repair a sudden, low-force fracture or a fragility fracture (the type of break that can happen from a minor fall or everyday activity, often linked to weaker bones).
  • People aged between 18 and 110 years old who are able to understand and agree to take part in the study. There is no upper age limit for this trial, but suitability for surgery is assessed individually, taking into account factors such as age, overall health, frailty, kidney function, and ability to give consent.

Who may not be able to join:

  • People who are not able to give informed consent to take part.
  • People who have a known or suspected cancer (malignancy).
  • People who have a known or suspected bone infection (osteomyelitis).
  • People who have a known or suspected bloodborne disease (confirm with trial site for specific conditions this covers).
  • People who are currently taking part in another clinical trial that involves an investigational medicine or drug.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Raghbir Khakha, Harley Street Specialist Hospital & Fitzrovia Hospital/QASMC

Phone: 447387227904

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Relation Therapeutics
Registry
ClinicalTrials.gov
Start date
12 January 2023
Est. completion
1 December 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Acquisition of bone waste

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov